Veracyte, Inc.
DE ˙ DB ˙ US92337F1075
40,53 € ↓ -2,45 (-5,70%)
2026-06-05
DEL PRIS
SecurityDE:12V / Veracyte, Inc.
InstitutionExchange Traded Concepts, Llc
Latest Disclosed Ownership145,925 shares
Latest Disclosed Value $ 4,700,244
Exchange Traded Concepts, Llc reports 31.53% increase in ownership of 12V / Veracyte, Inc.

On April 15, 2026 - Exchange Traded Concepts, Llc filed a 13F-HR form disclosing ownership of 145,925 shares of Veracyte, Inc. (DE:12V) valued at $3,881,605 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 14, 2026 disclosing 110,944 shares of Veracyte, Inc.. This represents a change in shares of 31.53% during the quarter. The current value of the position is $5,914,340 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F VERACYTE COM 92337F107 145,925 34,981 31.53 4,700 0.64 0.0333
2026-01-14 2025-12-31 13F VERACYTE COM 92337F107 110,944 -21,490 -16.23 4,671 2.73 0.0355
2025-10-14 2025-09-30 13F VERACYTE COM 92337F107 132,434 17,393 15.12 4,546 46.22 0.0387
2025-07-10 2025-06-30 13F VERACYTE COM 92337F107 115,041 23,047 25.05 3,110 14.01 0.0380
2025-04-17 2025-03-31 13F VERACYTE COM 92337F107 91,994 22,565 32.50 2,728 -0.80 0.0467
2025-01-21 2024-12-31 13F VERACYTE COM 92337F107 69,429 -21,414 -23.57 2,749 -11.09 0.0547
2024-10-10 2024-09-30 13F VERACYTE COM 92337F107 90,843 -41,458 -31.34 3,092 7.89 0.0723
2024-08-13 2024-06-30 13F VERACYTE COM 92337F107 132,301 -12,106 -8.38 2,867 -10.44 0.0725
2024-04-15 2024-03-31 13F VERACYTE COM 92337F107 144,407 50,506 53.79 3,200 23.89 0.0825
2024-01-05 2023-12-31 13F VERACYTE COM 92337F107 93,901 13,482 16.76 2,583 43.90 0.0690
2023-10-18 2023-09-30 13F VERACYTE COM 92337F107 80,419 11,966 17.48 1,796 2.98 0.0508
2023-07-20 2023-06-30 13F VERACYTE COM 92337F107 68,453 2,395 3.63 1,743 18.33 0.0429
2023-04-12 2023-03-31 13F VERACYTE COM 92337F107 66,058 8,804 15.38 1,473 8.47 0.0404
2023-01-27 2022-12-31 13F/A-1 VERACYTE COM 92337F107 57,254 -25,910 -31.16 1,359 -1.67 0.0389
2023-01-18 2022-12-31 13F VERACYTE COM 92337F107 57,254 -25,910 1 0.0389
2022-10-07 2022-09-30 13F VERACYTE COM 92337F107 83,164 -31,194 -27.28 1,381 -39.32 0.0452
2022-07-20 2022-06-30 13F VERACYTE COM 92337F107 114,358 6,072 5.61 2,276 -23.75 0.0662
2022-04-26 2022-03-31 13F VERACYTE COM 92337F107 108,286 13,328 14.04 2,985 -23.70 0.0599
2022-01-13 2021-12-31 13F VERACYTE COM 92337F107 94,958 13,284 16.26 3,912 3.11 0.0758
2021-10-18 2021-09-30 13F VERACYTE COM 92337F107 81,674 -31,353 -27.74 3,794 -16.04 0.0969
2021-07-30 2021-06-30 13F VERACYTE COM 92337F107 113,027 72,637 179.84 4,519 108.15 0.1430
2021-04-20 2021-03-31 13F VERACYTE COM 92337F107 40,390 19,481 93.17 2,171 112.22 0.0812
2021-01-19 2020-12-31 13F VERACYTE COM 92337F107 20,909 -1,995 -8.71 1,023 37.50 0.0475
2020-10-30 2020-09-30 13F VERACYTE COM 92337F107 22,904 7,892 52.57 744 91.26 0.0421
2020-07-15 2020-06-30 13F VERACYTE COM 92337F107 15,012 8,964 148.21 389 164.63 0.0645
2020-04-14 2020-03-31 13F VERACYTE COM 92337F107 6,048 3,113 106.06 147 79.27 0.0795
2020-01-22 2019-12-31 13F VERACYTE COM 92337F107 2,935 2,935 82 0.0171
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.